Walden Bjørn-Yoshimoto

Walden Bjørn-Yoshimoto serves as Assistant Professor in the Department of Biomedical Sciences within the Faculty of Health and Medical Sciences at the University of Copenhagen. His research focuses on molecular cardiology and membrane proteins, with specialization in cone snail peptides and their interactions with human neuropeptide systems.

Education:

• PhD in Pharmaceutical Sciences (2017), University of Copenhagen
• MSc in Biochemistry (2010), University of Copenhagen
• BSc in Biochemistry (2007), University of Copenhagen

Dr. Bjørn-Yoshimoto's research centers on cone snail peptides (conopeptides) that mimic endogenous neuropeptides, employing bioinformatics algorithms and functional pharmacological assays to identify novel sequences. His work particularly examines conopeptides that interact with G protein-coupled receptors (GPCRs), including somatostatin-mimicking peptides with non-opioid analgesic properties. This research has significant implications for developing alternatives to traditional opioids with fewer side effects and lower abuse potential.

Research Trends: Analysis of recent publications reveals a strong focus on venom evolution, peptide-receptor interactions, and therapeutic applications of conopeptides. His work bridges evolutionary biology, neuropharmacology, and drug discovery, with particular emphasis on non-opioid pain management solutions and metabolic regulation mechanisms.

Awards:

• 1st prize for best pitch and business concept (December 2, 2022)

Dr. Bjørn-Yoshimoto actively mentors students and welcomes research project inquiries through his laboratory. His work has garnered significant attention with coverage by 72 news outlets, mentions on 45 X (Twitter) accounts, references in Wikipedia, and substantial academic readership on Mendeley. His research group collaborates extensively internationally, with notable connections to researchers studying cone snail venoms and neuropeptide systems.

The researcher maintains laboratory facilities within the Molecular Cardiology and Membrane Proteins research section at the University of Copenhagen, with additional collaboration through the website https://helenasafavi.com. His work combines computational approaches with experimental pharmacology to advance understanding of peptide-based drug development.